Author + information
- Received April 24, 2017
- Revision received May 10, 2017
- Accepted May 23, 2017
- Published online October 18, 2017.
- Ignacio Cruz-Gonzalez, MD, PhD∗ (, )
- Monica Fuertes Barahona, MD,
- Jose Carlos Moreno-Samos, MD,
- Manuel Barreiro-Perez, MD, PhD,
- Javier Rodríguez Collado, MD,
- David Gonzalez-Calle, MD and
- Pedro L. Sanchez, MD, PhD
- ↵∗Address for correspondence:
Prof. Ignacio Cruz-Gonzalez, University Hospital of Salamanca, Cardiology Department, Paseo San Vicente 58-182, Salamanca, 37007, Spain.
A 76-year-old man with nonvalvular atrial fibrillation under oral anticoagulant treatment with direct inhibitor of factor Xa was admitted because of systemic embolism. Transesophageal echocardiogram showed a thrombus in a “chicken wing” left atrial appendage (LAA). The patient was discharged on apixaban, 5 mg every 12 hours. Transesophageal echocardiogram and cardiac tomography in the following months continued to show thrombus despite different anticoagulant treatments. The patient discontinued treatment because of a dental extraction, and he was admitted due to stroke. Transesophageal echocardiogram showed that the thrombus had reduced its size.
After discussion it was decided to perform LAA occlusion with a LAmbre device (Lifetech Scientific Inc., Shenzhen, China) and carotid filters to prevent further episodes. To avoid thrombus embolization, the umbrella of the device was partially deployed at the ostium of the appendage and it was advanced under simultaneous counterclockwise rotation (Figure 1). After confirmation of an optimal positioning no further repositioning maneuvers were made, the cover was deployed, and the device was delivered successfully (Figure 1). No thrombotic material was collected in the filters.
The data available in the published reports about LAA closure in patients with thrombus are sparse and a few techniques have been described (1). To the best of our knowledge this is the first reported case of LAA occlusion with the LAmbre in the presence of thrombus. This device recently obtained the Conformité Européenne mark. It is a self-expanded nitinol and polyester device composed of 2 parts: umbrella and cover (2). The distal aspect of umbrella is covered by polyethylene terephthalate membrane (Figure 2). This characteristic could make this device ideal for LAA occlusion with thrombus. The combination of the covered umbrella and the partial deployment at the ostium could potentially prevent thrombus migration.
All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received April 24, 2017.
- Revision received May 10, 2017.
- Accepted May 23, 2017.
- 2017 American College of Cardiology Foundation
- Bellmann B.,
- Rillig A.,
- Leistner D.M.,
- et al.
- Cruz-Gonzalez I.,
- Moreno-Samos J.C.,
- Rodriguez-Collado J.,
- Mo Y.,
- Lam Y.Y.,
- Sanchez P.L.